Think of biotech and the bioeconomy as a broad methodology encompassing all those who use and borrow from biology to produce ...

Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity was originally published by The Motley Fool ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

On the Readout LOUD podcast, hear what a Harris or Trump presidency would mean for health care policy, and learn about Eli ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

Wilmington Trust, the wealth management arm of M&T Bank, announced it has hired Karen… Shawmut Design and Construction, a $1.6 billion national construction management firm, celebrated the ...

Glassdoor, Payscale, or more specifically BioPharmGuy (to look through a large variety of job offers similar to yours) are ...

In the rapidly advancing field of biotechnology, precise analysis and accurate measurement are critical for research and ...

With Donald Trump now confirmed as the President-elect, the life sciences industry is bracing for significant policy shifts that could impact everything from drug pricing to regulatory practices. Trum ...

Election polls and betting markets are pointing to an increasingly tight presidential race, as investors brace for ...

Opthea is a clinical-stage biotech firm developing Sozinibercept, targeting VEGF-C and VEGF-D for wet AMD, with Phase 3 ...